EP3395814
Hemlar á viðtakann fyrir vaxtarþátt trefjakímfrumna
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.10.2014EP published:
6.4.2022EP application number:
18177131.2
EP translation filed:
29.6.2022Grant published:
15.8.2022EPO information:
European Patent Register
Max expiry date:
22.10.2034Expiry date:
22.10.2026Next due date:
31.10.2026
Title in English:
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTORLanguage of the patent:
English
Timeline
Today
23.10.2014EP application
6.4.2022EP Publication
29.6.2022Translation submitted
15.8.2022Registration published
22.10.2026Expires
Owner
Name:
Blueprint Medicines CorporationAddress:
45 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
BIFULCO, Neil Jr.Address:
Sudbury, MA 01776, US
Name:
DIPIETRO, Lucian V.Address:
Gloucester, MA 01930, US
Name:
HODOUS, Brian L.Address:
Cambridge, MA 02139, US
Name:
MIDUTURU, Chandrasekhar V.Address:
Cambridge, MA 02139, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361895472 PDate:
25.10.2013Country:
US
Number:
201461927782 PDate:
15.1.2014Country:
US
Classification
Categories:
C07D 403/12, C07D 401/04, C07D 401/12, C07D 235/30, C07D 405/12, C07D 403/14, C07D 409/12, A61K 31/498, A61P 35/00, C07D 239/84, C07D 471/04, C07D 475/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.1.2023
Expires: 22.10.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.10.2023
Expires: 22.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.9.2024
Expires: 22.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 30.10.2025
Expires: 22.10.2026
Payer: Árnason Faktor ehf.